C. Raut

PROFILE

Homepage
No homepage is listed.
ORCID
No ORCID is listed.
Affiliations
No affiliations are listed.
Aliases
C. Premanand Raut, Chandrajit Premanand Raut, Chandrajit P. Raut, C.p. Raut, C Raut, Chandrajit P Raut, C P Raut, Chandrajit Raut, C. P. Raut
Publication record
299 papers · 26,769 citations · H-index 68

PAPERS

Management of Recurrent Retroperitoneal Sarcoma
20237 citationsauthor #2
Creation and Implementation of a Monthly International Tumor Board: Experience of the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
20233 citationsauthor #3
Impact of pregnancy in women with desmoid fibromatosis: An international retrospective observational study.
20233 citationsauthor #4
Multidisciplinary approach for a high‐risk, localized soft tissue sarcoma of the trunk after unplanned nononcological resection
20232 citationsauthor #5
Abstract 3887: ATP-binding pocket substitutions as secondary or tertiary in-cis mutations are major on-target ripretinib resistance mechanisms in gastrointestinal stromal tumor
20230 citationsauthor #21
Correction: Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group
20221 citationsauthor #4
Management of Locally Recurrent Retroperitoneal Sarcoma in the Adult: An Updated Consensus Approach from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group
202238 citationsauthor #44
What enhanced recovery means for patients with cancer undergoing surgery
20221 citationsauthor #2
Dataset for reporting of gastrointestinal stromal tumours: recommendations from the International Collaboration on Cancer Reporting (ICCR)
20222 citationsauthor #7
Correction to: Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG)
20220 citationsauthor #2
So Now What? Unanswered Questions Regarding Retroperitoneal Sarcomas, Hospital Volume, Multidisciplinary Expertise, and Outcomes
20222 citationsauthor #2
Special clinical scenarios in RPS: Involvement ofgreat vessels and pancreas and penetration cross natural foramina.
20221 citationsauthor #3
Use of Neoadjuvant Imatinib to Facilitate Minimally Invasive Resection of Gastric Gastrointestinal Stromal Tumors
20225 citationsauthor #3
Sustained Supratherapeutic Paclitaxel Delivery Enhances Irreversible Sarcoma Cell Death.
20221 citationsauthor #13
ASO Visual Abstract: Gender Disparities in Presentations at the Society of Surgical Oncology (SSO) Meetings from 2014 to 2019
20220 citationsauthor #6
ASO Visual Abstract: Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas—A Systematic Review of the Literature
20220 citationsauthor #13
Relevant Trials Update in Sarcomas and Gastrointestinal Stromal Tumors: What Surgeons Should Know.
20224 citationsauthor #3
Abstract A013: CDK2 and CDK4/6 inhibition in GIST: Mechanisms of response and resistance
20220 citationsauthor #16
Retrospective Analysis of Retroperitoneal-Abdominal-Pelvic Ganglioneuromas
20229 citationsauthor #34
Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST
202223 citationsauthor #18
Gastrointestinal Stromal Tumors and the General Surgeon.
20229 citationsauthor #2
Preclinical modeling of leiomyosarcoma identifies susceptibility to transcriptional CDK inhibitors through antagonism of E2F-driven oncogenic gene expression.
20227 citationsauthor #12
Sentinel Lymph Node Biopsy for Extremity and Truncal Soft Tissue Sarcomas: A Systematic Review of the Literature
20225 citationsauthor #13
Correction to: Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
20220 citationsauthor #2
The Ever-Evolving Landscape of Sarcomas: A 2022 Update on This Complex Family of Diseases.
20220 citationsauthor #1
Development of an Electronic Health Record Registry to Facilitate Collection of Commission on Cancer Metrics for Patients Undergoing Surgery for Breast Cancer.
20222 citationsauthor #8
Retrospective observational studies in ultra-rare sarcomas: A consensus paper from the Connective Tissue Oncology Society (CTOS) community of experts on the minimum requirements for the evaluation of activity of systemic treatments.
202221 citationsauthor #41
Correction: ASO Visual Abstract: An Analysis of Differentiation Changes and Outcomes at the First Recurrence of Retroperitoneal Liposarcoma by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
20220 citationsauthor #2
Doxorubicin-Loaded Polymeric Meshes Prevent Local Recurrence After Sarcoma Resection While Avoiding Cardiotoxicity.
20222 citationsauthor #11
Gender Disparities in Presentations at the Society of Surgical Oncology (SSO) Meetings From 2014 to 2019
20224 citationsauthor #6
ASO Visual Abstract: Use of Neoadjuvant Imatinib to Facilitate Minimally Invasive Resection of Gastric Gastrointestinal Stromal Tumors
20220 citationsauthor #3
Preoperative Radiotherapy in Patients With Primary Retroperitoneal Sarcoma
2022102 citationsauthor #2
Abstract 5648: Response and resistance to CDK2 and CDK4/6 inhibition in GIST
20220 citationsauthor #15
Longitudinal prognostication in retroperitoneal sarcoma survivors: Development and external validation of two dynamic nomograms.
202123 citationsauthor #19
Epithelioid hemangioendothelioma, an ultra-rare cancer: a consensus paper from the community of experts
2021152 citationsauthor #61
Morbidity and Outcomes After Distal Pancreatectomy for Primary Retroperitoneal Sarcoma: An Analysis by the Trans-Atlantic Australasian Retroperitoneal Sarcoma Working Group
202117 citationsauthor #4
Adjuvant therapy for primary GIST: is longer really better? A narrative review
20212 citationsauthor #2
Analysis of Differentiation Changes and Outcomes at Time of First Recurrence of Retroperitoneal Liposarcoma by Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
202120 citationsauthor #2
Management of Primary Retroperitoneal Sarcoma (RPS) in the Adult: An Updated Consensus Approach from the Transatlantic Australasian RPS Working Group
2021204 citationsauthor #32
ASO Author Reflections: Selecting Patients for Recurrent Retroperitoneal Sarcoma Surgery: The Challenging Trade-Off Between Oncologic Outcome and Morbidity
20212 citationsauthor #3
Retroperitoneal sarcoma: the Transatlantic Australasian Retroperitoneal Sarcoma Working Group Program
202115 citationsauthor #2
Ultra‐rare sarcomas: A consensus paper from the Connective Tissue Oncology Society community of experts on the incidence threshold and the list of entities
2021181 citationsauthor #37
Clinical outcomes following high-dose-rate surface applicator brachytherapy for angiosarcoma of scalp and face
20217 citationsauthor #6
Postnephrectomy outcomes following en bloc resection of primary retroperitoneal sarcoma: multicentre study.
20212 citationsauthor #10
ASO Visual Abstract: An Analysis of Differentiation Changes and Outcomes at the First Recurrence of Retroperitoneal Liposarcoma by the Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG)
20210 citationsauthor #2
Gastrointestinal stromal tumors: Lessons learned after 1,000 patients and 34 years
20211 citationsauthor #1
Postoperative Morbidity After Resection of Recurrent Retroperitoneal Sarcoma: A Report from the Transatlantic Australasian RPS Working Group (TARPSWG)
202135 citationsauthor #2
Breast Sarcomas, Phyllodes Tumors, and Desmoid Tumors: Epidemiology, Diagnosis, Staging, and Histology-Specific Management Considerations.
202121 citationsauthor #2
Traveling to Receive Treatment for Extremity Soft Tissue Sarcomas: Is it worth the drive?
20212 citationsauthor #2
Defining the role of neoadjuvant systemic therapy in high-risk retroperitoneal sarcoma: A multi-institutional TARPSWG study.
20202 citationsauthor #13
Has the Outcome for Patients Who Undergo Resection of Primary Retroperitoneal Sarcoma Changed Over Time? A Study of Time Trends During the Past 15 years
202048 citationsauthor #2
Oncogenic Gene-Expression Programs in Leiomyosarcoma and Characterization of Conventional, Inflammatory, and Uterogenic Subtypes
202026 citationsauthor #3
Virtual Biobanking for Retroperitoneal Sarcoma: A Transatlantic Australasian Retroperitoneal Sarcoma Working Group (TARPSWG) Initiative
20202 citationsauthor #5
Management of meningeal solitary fibrous tumors/hemangiopericytoma; surgery alone or surgery plus postoperative radiotherapy?
202023 citationsauthor #9
Nephrectomy for Retroperitoneal Sarcoma: Stay Calm and (Cautiously) Carry On
20202 citationsauthor #2
The management of desmoid tumours: A joint global consensus-based guideline approach for adult and paediatric patients.
2020398 citationsauthor #42
Angiosarcoma of the Scalp and Face: A Dosimetric Comparison of HDR Surface Applicator Brachytherapy and VMAT
20206 citationsauthor #6
Diagnosis and management of tropomyosin receptor kinase (TRK) fusion sarcomas: expert recommendations from the World Sarcoma Network
2020126 citationsauthor #28
The Landmark Series: Systemic Therapy for Resectable Gastrointestinal Stromal Tumors
202018 citationsauthor #2
Defining the role of neoadjuvant systemic therapy in high‐risk retroperitoneal sarcoma: A multi‐institutional study from the Transatlantic Australasian Retroperitoneal Sarcoma Working Group
202047 citationsauthor #12
Characteristics of atypical post-radiation vascular proliferation: a retrospective review of 193 patients.
202011 citationsauthor #2
Preoperative radiotherapy plus surgery versus surgery alone for patients with primary retroperitoneal sarcoma (EORTC-62092: STRASS): a multicentre, open-label, randomised, phase 3 trial.
2020351 citationsauthor #12
Surgical Oncology
20200 citationsauthor #2
Racial Differences in Extremity Soft Tissue Sarcoma Treatment in a Universally Insured Population.
202010 citationsauthor #7
Enhanced recovery after surgery pathway in patients with soft tissue sarcoma
202021 citationsauthor #8
Primary intra‐abdominal melanoma arising in association with extracutaneous blue naevus: a report of two cases
20204 citationsauthor #5
Patterns of recurrence and survival probability after second recurrence of retroperitoneal sarcoma: A study from TARPSWG
202031 citationsauthor #26
Strategies for care of patients with gastrointestinal stromal tumor or soft tissue sarcoma during COVID‐19 pandemic: A guide for surgical oncologists
20208 citationsauthor #2
Enhanced recovery after surgery pathway in patients with soft tissue sarcoma
20200 citationsauthor #2
Desmoid tumors: To treat or not to treat, That is the question
202055 citationsauthor #2
Virtual Interviews for the Complex General Surgical Oncology Fellowship: The Dana-Farber/Partners Experience
202022 citationsauthor #5
Extrameningeal solitary fibrous tumors—surgery alone or surgery plus perioperative radiotherapy: A retrospective study from the global solitary fibrous tumor initiative in collaboration with the Sarcoma Patients EuroNet
202065 citationsauthor #8
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
2019126 citationsauthor #11
Predicting Survival in Patients Undergoing Resection for Locally Recurrent Retroperitoneal Sarcoma: A Study and Novel Nomogram from TARPSWG
201997 citationsauthor #1
The opportunities and shortcomings of using big data and national databases for sarcoma research
201957 citationsauthor #4
Defining Rupture in Gastrointestinal Stromal Tumor: Semantics and Prognostic Value
20195 citationsauthor #4
Defining Tumor Rupture in Gastrointestinal Stromal Tumor
201975 citationsauthor #3
The Angiosarcoma Project: enabling genomic and clinical discoveries in a rare cancer through patient-partnered research
2019229 citationsauthor #14
Genomic Evolutionary Patterns of Leiomyosarcoma and Liposarcoma
201922 citationsauthor #16
To Biopsy, or Not to Biopsy: Is There Really a Question?
20198 citationsauthor #2
OC-0070 Radiation Therapy for Retroperitoneal Liposarcoma – A report from TARPSWG
20190 citationsauthor #19
Genomic aberrations in cell cycle genes predict progression of KIT-mutant gastrointestinal stromal tumors (GISTs)
201938 citationsauthor #9
Decreased Recurrence in Sarcoma Patient-Derived Xenografts Using Paclitaxel-Eluting Polymer Films
20190 citationsauthor #8
A Comparison of Outcomes and Prognostic Features for Radiation-Associated Angiosarcoma of the Breast and Other Radiation-Associated Sarcomas.
201938 citationsauthor #7
Altered chromosomal topology drives oncogenic programs in SDH-deficient GISTs
2019207 citationsauthor #9
Screening populations at high risk for soft tissue sarcoma and surveillance following soft tissue sarcoma resection
20198 citationsauthor #3
Gastrointestinal stromal tumors: bench to bedside
20191 citationsauthor #2
Enhancer Domains in Gastrointestinal Stromal Tumor Regulate KIT Expression and Are Targetable by BET Bromodomain Inhibition.
201921 citationsauthor #7
Molecular characterization and management of secondary resistance to serial TRK inhibitors.
20191 citationsauthor #11
Detection of Circulating Tumor DNA in Patients With Leiomyosarcoma With Progressive Disease.
201949 citationsauthor #10
Intercontinental collaborative experience with abdominal, retroperitoneal and pelvic schwannomas
201916 citationsauthor #25
Survey of Surgical Oncology Fellowship Graduates 2005–2016: Insight into Initial Practice
201919 citationsauthor #7
STRASS (EORTC 62092): A phase III randomized study of preoperative radiotherapy plus surgery versus surgery alone for patients with retroperitoneal sarcoma.
201983 citationsauthor #14
Abstract B085: High mutation burden and response to immune checkpoint inhibitors in angiosarcomas of the scalp and face
20192 citationsauthor #18
OTT_A_180763 5123..5133
201936 citationsauthor #2
Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours
20196 citationsauthor #11
Diagnosis and management of a recurrent polymerase-epsilon (POLE)-mutated endometrial cancer.
201926 citationsauthor #8
New research strategies in retroperitoneal sarcoma. The case of TARPSWG, STRASS and RESAR: making progress through collaboration.
201960 citationsauthor #2
Radiotherapy for retroperitoneal liposarcoma: A report from the Transatlantic Retroperitoneal Sarcoma Working Group
201986 citationsauthor #19
Oncogenic Signaling Pathways in The Cancer Genome Atlas.
20182,523 citationsauthor #306

TIMELINE

2003 313 citations

2004 1,065 citations

2005 300 citations

2006 703 citations

2007 1,570 citations

2008 607 citations

2009 462 citations

2010 1,283 citations

2011 326 citations

2012 1,062 citations

2013 445 citations

2014 539 citations

2015 97 citations

2016 945 citations

2017 2,304 citations

2018 11,252 citations

2019 1,316 citations

2020 1,276 citations

2021 684 citations

2022 239 citations

2023 15 citations

C. Raut

PROFILE

PAPERS

TIMELINE

COAUTHOR MAP

CONCEPT FOOTPRINT